Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.10 and traded as high as C$0.11. Resverlogix shares last traded at C$0.11, with a volume of 21,242 shares traded.
Resverlogix Trading Up 10.0%
The company has a debt-to-equity ratio of -10.95, a quick ratio of 0.04 and a current ratio of 0.13. The stock has a market cap of C$31.61 million, a P/E ratio of -3.67 and a beta of 0.70. The stock has a 50-day moving average price of C$0.10 and a 200-day moving average price of C$0.10.
Resverlogix (TSE:RVX – Get Free Report) last posted its quarterly earnings data on Thursday, November 13th. The biotechnology company reported C$0.00 earnings per share for the quarter. On average, equities research analysts expect that Resverlogix Corp. will post -0.22 EPS for the current year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
See Also
- Five stocks we like better than Resverlogix
- Unlocked: Elon Musk’s Next Big IPO
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What Expenses Can Be Deducted From Capital Gains Tax This Year?
- The gold chart Wall Street is terrified of…
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
